Print Icon

Not displaying correctly? View in Browser



THBI is actively communicating and working with elected officials, state agencies, industry partners and Texas entities to ensure the state of Texas is on the forefront of combating coronavirus, and taking proper action to keep the state safe during the global outbreak. We will be providing our partners regular updates on how our industry is responding to the epidemic. 

Texas Supply Chain Strike Force

This past Sunday, Governor Greg Abbott announced the creation of a Supply Chain Strike Force. The Strike Force is guiding collaboration between the public and private sectors to ensure health care facilities have the supplies and resources they need to respond to COVID-19.The Strike Force needs your help to secure necessary large quantities of critically-needed personal protective equipment (PPE) items such as masks (N95 and/or surgical), respirators, ventilators, gowns, and gloves. 

If you have readily-available supply or can quickly produce large quantities of critically-needed items, please complete the State’s procurement form:

If you would like to have other impact by providing other readily-available items that can assist our medical and public health professionals, please complete the State’s volunteer and donation assistance form:

For more information on the State’s efforts related to COVID-19, please visit


Updates from the Texas Legislature

Governor Abbott Announces Increased PPE Supply, Issues Executive Order To Strengthen Reporting Capabilities

The Governor announced that the newly established Supply Chain Strike Force has already secured more than $83 million of purchase orders for essential supplies. Additionally, he announced that the Texas Division of Emergency Management will begin receiving 100,000 masks per day by the end of this week.

Governor Abbott Announces Distribution Of Federal Funding For COVID-19 Response

Texas has received $36.9 million from the Centers for Disease Control and Prevention (CDC) as part of the state's initial allotment of funding from the first emergency coronavirus bill passed by Congress. 

Texas' Response

Texas Research Community Works Together to Combat COVID-19

From reworking a vaccine meant to combat SARS nearly 20 years ago, to collaborating with other labs in Texas and around the world, to trying to secure new answers on how COVID-19 spreads and how communities should react, our state’s scientific leaders are working around the clock to find answers and mitigate harm.

THBI President's Call: March 26

This month’s members-only call brings together special guests Dan Hargrove, President and co-founder of Cancer Insight, and co-founder of Trauma Insight, and Larry Schlesinger, MD, CEO of Texas Biomedical Research Institute for an informative conversation on COVID-19, “Answering the Call of Duty. What Texans are doing to combat the coronavirus? How THBI members can help the Nation and World in this time of crisis.” 

BIO Business Solutions

As the world has been dealing with the implications of the COVID-19 pandemic, BIO has been working with partners and member companies on business continuity, mitigation and contingency planning. As part of BIO Business Solutions Cost Savings Program, we have several benefits to help you run your business, access resources and reduce spending.

Working from Home Solutions - Save up to 80% on select office products

Access resources to develop new treatments for COVID-19 and other diseases from 3,300+ global suppliers.

Decontamination and Disposal of virus-infected sites

To become a THBI member and gain access to the BIO Business Solutions purchasing program, email

Stay Connected

THBI has published a COVID-19 page on for helpful resources and an archive of the THBI COVID-19 email updates. 

Our Members Response

Genentech Announces FDA Approval of Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumonia
Genentech announced the FDA has approved a randomized, double-blind, placebo-controlled Phase III clinical trial to evaluate the safety and efficacy of intravenous Actemra® plus standard of care in hospitalized adult patients with severe COVID-19 pneumonia. Genentech will provide 10,000 vials of Actemra to the U.S. Strategic National Stockpile for potential future use at the direction of the U.S. Department of Health and Human Services. 

Texas State University Small Business Development Center's Executive Director Joe Harper hosts webinar on the latest information surrounding small businesses and COVID-19
America’s SBDCs are working to help small businesses address the business challenges of the coronavirus disease 2019 (COVID-19) pandemic. 

Bayer donates three million malaria tablets to U.S. for potential use against coronavirus
Resochin, made of chloroquine phosphate and an approved treatment for malaria, is being evaluated in China for its potential use against COVID-19, the disease caused by the fast-spreading coronavirus.

Confinement requires new ways for families and caregivers to get access to resources they need and creativity to put those things at their fingertips
While the global coronavirus pandemic is experienced differently by everyone, the effect on individuals with Duchenne, their families and caregivers, carries greater weight due to the health complexities that Duchenne presents.  

CRB on managing supply chain disruptions in the pharmaceutical industry
Most of the concern is currently on finding a vaccine and creating the process and facilities to manufacture it quickly, at-scale. But there is also the possibility that many people all over the world may have difficulty getting other essential medicines because resources will be diverted to the manufacture of an eventual vaccine.

Industry Welcomes Government Direction On Allocation of Ventilators
Advanced Medical Technology Association (AdvaMed) sent a letter to FEMA and the administration  to address the coronavirus pandemic and help ensure appropriate access for medical ventilators to health care providers and patients.

Resource Center

Texas Workforce Commission (TWC)
At TWC, the health and well-being of our employers, employees and communities is our top priority. We understand the concern and uncertainty you may be experiencing surrounding the coronavirus (COVID-19) and are committed to being responsive to the needs of our customers.

Texas Department of State Health Services (DSHS)

DSHS is responding COVID-19 outbreak that originated in Wuhan, China. For prevention tips, symptoms, traveler information, and healthcare provider resources, see our COVID-19 website.

Centers for Disease Control and Prevention (CDC)

CDC works 24/7 to protect America from health, safety and security threats, both foreign and in the U.S. They are closely monitoring an outbreak caused COVID-19 and are the go to resource for the U.S.

Biotechnology Innovation Organization (BIO) Coronavirus Business Resource Center

As many BIO members work to develop diagnostics, vaccines and treatments to address the global COVID-19 outbreak, BIO has provided resources to help companies continue their operations with minimum disruption and keep their employees safe and healthy. 

Copyright © 2020 THBI. All rights reserved.

Our mailing address is:
807 Brazos Street, Suite 607Austin, TX 78701

This message is sent to you because your email address is on our subscribers list. If you are not interested in receiving more emails like this one, click here to unsubscribe.